Declarations of pharma funding are still not transparent enough, say critics

Exact details of the £542.9m (€605.8m; $725m) that drug companies spent on healthcare organisations and healthcare professionals in 2019 have been disclosed—five months later than planned, as a…


Read Original Article: Declarations of pharma funding are still not transparent enough, say critics »